Form SC 13G/A Response Oncology Inc

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

Published: 2000-02-10 00:00:00
Submitted: 2000-02-10
0000859780-00-000011.txt Complete submission text file
-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Aau15O8kkH0PGP5QoY5VhclEkWlIcdLHA2br+Sl241e2zYQFvALnZo1CMJJOom54
 Z71ujDCZXaZuOPC3B/nsJA==

<SEC-DOCUMENT>0000859780-00-000011.txt : 20000211
<SEC-HEADER>0000859780-00-000011.hdr.sgml : 20000211
ACCESSION NUMBER:		0000859780-00-000011
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20000210

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RESPONSE ONCOLOGY INC
		CENTRAL INDEX KEY:			0000763098
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		IRS NUMBER:				621212264
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		
		SEC FILE NUMBER:	005-37885
		FILM NUMBER:		530328

	BUSINESS ADDRESS:	
		STREET 1:		1775 MORIAH WOODS BLVD
		CITY:			MEMPHIS
		STATE:			TN
		ZIP:			38117
		BUSINESS PHONE:		9017617000

	MAIL ADDRESS:	
		STREET 1:		1775 MORIAH WOODS BLVD
		CITY:			MEMPHIS
		STATE:			TN
		ZIP:			38117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RESPONSE TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19891221

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DALTON GREINER HARTMAN MAHER & CO /ADV
		CENTRAL INDEX KEY:			0000859780
		STANDARD INDUSTRIAL CLASSIFICATION:	 []
		IRS NUMBER:				593418454
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		1100 FIFTH AVE SOUTH STE 301
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34102
		BUSINESS PHONE:		9412613555

	MAIL ADDRESS:	
		STREET 1:		1100 FIFTH AVENUE SOUTH
		STREET 2:		SUITE 301
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DALTON GREINER HARTMAN MAHER & CO                       /ADV
		DATE OF NAME CHANGE:	19980210
</SEC-HEADER>

Form SC 13G/A 1


                       SECURITY AND EXCHANGE COMMISSION
                          Washington, DC 20549


                               SCHEDULE 13G
                Under the Securities Exchange Act of 1934
                            (Amendment No. 1)



    				 RESPONSE ONCOLOGY INC.
                           (Name of Issuer)

                            Common Stock
                    (Title of Class of Securities)


                          	761232305
                              (Cusip #)




Cusip No.    761232305         13G                Page 1 of 3 Pages

1  Name of Reporting Person
        Dalton, Greiner, Hartman, Maher & Co
        IRS Identification 59-3418454

2) Check the Appropriate box if a Member of a group*

3) SEC Use Only

4) Citizenship or place of Organization
        Delaware Partnership

Number of Shares Beneficially Owned by Each Reporting Person With:

   5) Sole Voting Power
      874,800

   6) Shared Voting Power
      0

   7) Sole Dispositive Power
      874,800

   8) Shared Dispositve Power
      0

9) Aggregate Amount Beneficially owned by each reporting person
      874,800

10) Check Box if the aggregate amount in row (9) excludes certain Shares

11) Percent of Class Represented by Amount in Row 9
      7.31%

12) Type of Reporting Person
      IA

Cusip No.    761232305          13G                Page 2 of 3 Pages

Item 1(a).  Name of Issuer:
            RESPONSE ONCOLOGY INC.

Item 1(b).  Address of Issuer's Principal Executive Office:
            1775 MORIAH WOODS BOULEVARD
            MEMPHIS, TN  38117

Item 2(a).  Name of Person Filing:
            Dalton, Greiner, Hartman, Maher & Co

Item 2(b).  Address of Principal Business Office:
            1100 Fifth Avenue South, Suite 301
            Naples, FL 34102

Item 2(c).  Citizenship:
            Delaware Partnership

Item 2(d).  Title of Class of Securities:
            Common Stock

Item 2(e).  CUSIP Number
            761232305

Item 3.     This statement is filed pursuant to Rules 13d-
            1(b), or 13d-2(b), the person filing is an
            Investment Adviser registered under Section 203
            of the Investment Advisers Act of 1940.

Item 4.  Ownership:
         (a)  Amount beneficially owned:
              874,800 shares

         (b)  Percent of Class:
              7.31%

         (c)  Number of shares as to which such person has:
              (i)  sole power to vote or to direct the vote:
                   874,800 shares
              (ii) shared power to vote or to direct the vote:
                   0 shares
              (iii) sole power to dispose or to direct the disposition:
                   874,800 shares
              (iv) shared power to dispose or to direct the disposition:
                   0 shares

Item 5. Ownership of Five Percent of Less of a Class :
        Not Applicable

Item 6. Ownership of more than five percent on behalf of another person:
        Not Applicable

Item 7. Identification and Classification of the subsidiary which acquired
        the security being reported on by the parent holding company:
        Not Applicable

Item 8. Identification and Classification of Members of the Group:
        Not Applicable

Cusip No.    7621232305       13G                Page 3 of 3 Pages

Item 9. Notice of Dissolution of Group:
        Not Applicable

Item 10. Certification :
        The following certification shall be included if the
        statement is filed pursuant to Rule 13d-1(b):

        By signing below I certify that, to the best of my knowledge
        and belief, the securities referred to above were acquired
        in the ordinary  course of business and were not acquired for
        the purpose of and do not have the effect of changing or
        influencing the control of the issuer of such securities and
        were not acquired in connection with or as a participant in
        any transaction having such purposes of effect.

        After reasonable inquiry and to the best of my knowledge and
        belief, I certify that the information set forth in this
        statement is true, complete and correct.

        February 10, 2000

        Dalton, Greiner, Hartman, Maher & Co
        By : /s/Michael W. Keeler
        Title : Vice President-Finance






 
 
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
Additional Files
FileSequenceDescriptionTypeSize
0000859780-00-000011.txt   Complete submission text file   6568

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.